BidaskClub upgraded shares of Shire (NASDAQ:SHPG) from a sell rating to a hold rating in a research note issued to investors on Thursday morning.

A number of other analysts have also recently issued reports on the stock. Berenberg Bank cut shares of Shire from a buy rating to a hold rating in a research note on Friday, September 7th. ValuEngine cut shares of Shire from a hold rating to a sell rating in a research note on Thursday, September 6th. Evercore ISI cut shares of Shire from an outperform rating to a market perform rating and set a $196.00 target price for the company. in a research note on Tuesday, September 4th. Sanford C. Bernstein cut shares of Shire from an outperform rating to a market perform rating in a research note on Tuesday, September 4th. Finally, Cantor Fitzgerald set a $222.00 target price on shares of Shire and gave the company a buy rating in a research note on Tuesday, July 31st. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and ten have assigned a buy rating to the stock. The company has an average rating of Hold and a consensus price target of $200.75.

NASDAQ SHPG opened at $177.30 on Thursday. The company has a quick ratio of 1.02, a current ratio of 1.55 and a debt-to-equity ratio of 0.45. The company has a market capitalization of $52.51 billion, a price-to-earnings ratio of 11.70, a price-to-earnings-growth ratio of 1.53 and a beta of 1.22. Shire has a 12-month low of $123.73 and a 12-month high of $177.75.

Shire (NASDAQ:SHPG) last posted its earnings results on Tuesday, July 31st. The biopharmaceutical company reported $3.88 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $3.67 by $0.21. The firm had revenue of $3.92 billion during the quarter. Shire had a net margin of 31.06% and a return on equity of 13.22%. Shire’s revenue was up 4.6% compared to the same quarter last year. During the same quarter last year, the firm earned $3.73 earnings per share. analysts anticipate that Shire will post 15.27 EPS for the current fiscal year.

The company also recently declared a dividend, which will be paid on Friday, October 19th. Stockholders of record on Friday, September 7th will be given a $0.168 dividend. The ex-dividend date is Thursday, September 6th. Shire’s dividend payout ratio is 2.24%.

Several large investors have recently added to or reduced their stakes in SHPG. Comerica Bank raised its position in shares of Shire by 9.7% in the first quarter. Comerica Bank now owns 23,690 shares of the biopharmaceutical company’s stock valued at $3,808,000 after purchasing an additional 2,089 shares during the period. SG Americas Securities LLC raised its position in shares of Shire by 29.3% in the first quarter. SG Americas Securities LLC now owns 11,159 shares of the biopharmaceutical company’s stock valued at $1,667,000 after purchasing an additional 2,529 shares during the period. M&T Bank Corp raised its position in shares of Shire by 10.1% in the first quarter. M&T Bank Corp now owns 7,185 shares of the biopharmaceutical company’s stock valued at $1,073,000 after purchasing an additional 658 shares during the period. Neuberger Berman Group LLC raised its position in shares of Shire by 22.2% in the first quarter. Neuberger Berman Group LLC now owns 51,551 shares of the biopharmaceutical company’s stock valued at $7,701,000 after purchasing an additional 9,352 shares during the period. Finally, Timber Hill LLC bought a new position in shares of Shire in the first quarter valued at approximately $291,000. 17.86% of the stock is currently owned by institutional investors.

About Shire

Shire plc, a biotechnology company, researches, develops, licenses, manufactures, markets, distributes, and sells medicines for rare diseases and other specialized conditions worldwide. The company offers products in therapeutic areas, including hematology, genetic diseases, neuroscience, immunology, internal medicine, ophthalmology, and oncology.

Featured Article: How Important is Technical Analysis of Stocks

Analyst Recommendations for Shire (NASDAQ:SHPG)

Receive News & Ratings for Shire Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shire and related companies with MarketBeat.com's FREE daily email newsletter.